RADX

0.63046.33%
IT

Ian Turner

Independent Non-Executive Director

Mr. Ian Turner serves as the Chief Executive Officer of TURNER Group LLC Since 2013. Mr. Turner has been Independent Non-Executive Director at Radiopharm Theranostics Limited since February 2021. He serves as a Director of AtomVie Glbl Radiopharma Inc He served as Chief Executive Officer and President at Siemens and was responsible for the global business for Cyclotrons and PETNET, which operates the largest PET radiopharmaceutical network in the world. Mr. Turner served as a Director of Coquí RadioPharmaceuticals, Corp. until 2019. He has also served on the Organization for Economic Co-operation and Development's (OECD) High-level Group on the Security of Supply of Medical Radioisotopes. Since August 2022, he is also non-executive director at AtomVie Global Radiopharma Inc, a global contract development and manufacturing organization, launched by the Centre for Probe Development and Commercialisation (CPDC). Mr. Turner was a director of Coqui Pharmaceuticals from November 2014 to March 2019. Mr. Turner was Chief Executive Officer at Siemens Radiopharmaceuticals, which operated a large global PET radio-pharmacy network, from 2010 to 2012. Prior to that, he was General Manager of ANSTO Radiopharmaceuticals, which was Australia’s leading manufacturer of radioisotopes for the nuclear medicine sector.

Positions